
                                SEQUENCE LISTING

<110> Tolero Pharmaceuticals, Inc.
      Bearss, David J.
      Siddiqui-Jain, Adam
      Whatcott, Clifford J.
      Warner, Steven L.
      
<120> COMPOSITIONS AND METHODS FOR TREATING CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING MCL-1 INHIBITORS

<130> 910208.431WO

<140> PCT                 
<141> 2018-09-12

<150> US 62/557,635
<151> 2017-09-12

<160> 2

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 37
<212> PRT
<213> Artificial Sequence

<220> 
<223> profiling peptide sequence

<400> 1
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly Gly Arg Pro
 1               5                  10                  15
Glu Ile Trp Met Thr Gln Gly Leu Arg Arg Leu Gly Asp Glu Ile Asn
            20                  25                  30
Ala Tyr Tyr Ala Arg
        35

<210> 2
<211> 37
<212> PRT
<213> Artificial Sequence

<220> 
<223> profiling peptide sequence

<400> 2
Arg Pro Glu Ile Trp Met Thr Gln Gly Leu Arg Arg Leu Gly Asp Glu
 1               5                  10                  15
Ile Asn Ala Tyr Tyr Ala Arg Gly Gly Gly Tyr Gly Arg Lys Lys Arg
            20                  25                  30
Arg Gln Arg Arg Arg
        35

